Literature DB >> 2328197

Comparative effects of ciprofloxacin and lomefloxacin on the oxidative metabolism of theophylline.

R A Robson1, E J Begg, H C Atkinson, D A Saunders, C M Frampton.   

Abstract

Nine healthy male volunteers were studied to assess the interaction between theophylline and ciprofloxacin and to assess whether a similar interaction occurred with lomefloxacin, using a randomised, crossover design. Subjects received theophylline 125 mg 8 hourly with and without lomefloxacin 400 mg 12 hourly or ciprofloxacin 500 mg 12 hourly for 7 days. Ciprofloxacin treatment lowered total theophylline clearance by 27%, owing to a decreased clearance via 1-, 3-demethylation and 8-hydroxylation. Lomefloxacin treatment did not alter theophylline clearance. Ciprofloxacin, at usual clinical doses, could cause a clinically significant interaction when co-administered with theophylline.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2328197      PMCID: PMC1380121          DOI: 10.1111/j.1365-2125.1990.tb03669.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  6 in total

1.  Selective inhibitory effects of nifedipine and verapamil on oxidative metabolism: effects on theophylline.

Authors:  R A Robson; J O Miners; D J Birkett
Journal:  Br J Clin Pharmacol       Date:  1988-03       Impact factor: 4.335

2.  Comparison of theophylline and theobromine metabolism in man.

Authors:  D J Birkett; R Dahlqvist; J O Miners; A Lelo; B Billing
Journal:  Drug Metab Dispos       Date:  1985 Nov-Dec       Impact factor: 3.922

3.  The theophylline-enoxacin interaction: I. Effect of enoxacin dose size on theophylline disposition.

Authors:  M C Rogge; W R Solomon; A J Sedman; P G Welling; R D Toothaker; J G Wagner
Journal:  Clin Pharmacol Ther       Date:  1988-11       Impact factor: 6.875

4.  The influence of quinolone derivatives on theophylline clearance.

Authors:  W J Wijnands; T B Vree; C L van Herwaarden
Journal:  Br J Clin Pharmacol       Date:  1986-12       Impact factor: 4.335

5.  Characterisation of theophylline metabolism in human liver microsomes.

Authors:  R A Robson; A P Matthews; J O Miners; M E McManus; U A Meyer; P M Hall; D J Birkett
Journal:  Br J Clin Pharmacol       Date:  1987-09       Impact factor: 4.335

6.  Predicting the ciprofloxacin-theophylline interaction from single plasma theophylline measurements.

Authors:  K A Bachmann; J I Schwartz; L Jauregui
Journal:  Br J Clin Pharmacol       Date:  1988-08       Impact factor: 4.335

  6 in total
  19 in total

1.  Effect of ciprofloxacin on antipyrine pharmacokinetics and metabolism in rats.

Authors:  A Anadón; M R Martinez-Larrañaga; M C Fernandez; M J Diaz; P Bringas
Journal:  Antimicrob Agents Chemother       Date:  1990-11       Impact factor: 5.191

Review 2.  Lomefloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  A N Wadworth; K L Goa
Journal:  Drugs       Date:  1991-12       Impact factor: 9.546

3.  Quantitative Prediction of Drug Interactions Caused by CYP1A2 Inhibitors and Inducers.

Authors:  Laurence Gabriel; Michel Tod; Sylvain Goutelle
Journal:  Clin Pharmacokinet       Date:  2016-08       Impact factor: 6.447

4.  Ciprofloxacin-induced theophylline toxicity: a population-based study.

Authors:  Tony Antoniou; Tara Gomes; Muhammad M Mamdani; David N Juurlink
Journal:  Eur J Clin Pharmacol       Date:  2011-01-14       Impact factor: 2.953

5.  Lack of interaction between lomefloxacin and caffeine in normal volunteers.

Authors:  D P Healy; J R Schoenle; J Stotka; R E Polk
Journal:  Antimicrob Agents Chemother       Date:  1991-04       Impact factor: 5.191

Review 6.  Influence of endogenous and exogenous effectors on the pharmacokinetics of theophylline. Focus on biotransformation.

Authors:  U Tröger; F P Meyer
Journal:  Clin Pharmacokinet       Date:  1995-04       Impact factor: 6.447

7.  The effect of ciprofloxacin on theophylline pharmacokinetics in healthy subjects.

Authors:  K T Batty; T M Davis; K F Ilett; L J Dusci; S R Langton
Journal:  Br J Clin Pharmacol       Date:  1995-03       Impact factor: 4.335

Review 8.  Drug interactions with quinolone antibacterials.

Authors:  J R Brouwers
Journal:  Drug Saf       Date:  1992 Jul-Aug       Impact factor: 5.606

Review 9.  Lomefloxacin clinical pharmacokinetics.

Authors:  C D Freeman; D P Nicolau; P P Belliveau; C H Nightingale
Journal:  Clin Pharmacokinet       Date:  1993-07       Impact factor: 6.447

10.  Relationship between enoxacin and ciprofloxacin plasma concentrations and theophylline disposition.

Authors:  J D Davis; L Aarons; J B Houston
Journal:  Pharm Res       Date:  1994-10       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.